Sign in

CIK 0001856725

  • Emerging growth company

Rani Therapeutics Holdings, Inc.

Sign in to watch
Ticker
RANI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
863114789
Phone
+1 408-457-3700
Business address
47709 FREMONT BLVD, FREMONT, CA, 94538
  1. 4 Open-market buy 10% owner bought 3,587 shares at $5.23 ($18,749)
  2. 4 Open-market buy 10% owner bought 12,981 shares at an average $4.80 ($62,374)
  3. 4 Open-market buy 10% owner bought 3,510 shares at $5.49 ($19,283)
  4. 4 Grant or award GENERAL COUNSEL acquired 139,000 shares (grant or award)
  5. 4 Grant or award CHIEF SCIENTIFIC OFFICER acquired 139,000 shares (grant or award)
  6. 4 Grant or award CFO acquired 139,000 shares (grant or award)
  7. 4 Grant or award CEO acquired 353,500 shares (grant or award)
  8. 4 Shares withheld for taxes CFO gave up 3,355 shares (to pay taxes)
  9. 4 Shares withheld for taxes General Counsel gave up 2,498 shares (to pay taxes)
  10. 4 Shares withheld for taxes CEO gave up 7,988 shares (to pay taxes)
  11. 4 Shares withheld for taxes Chief Scientific Officer gave up 4,201 shares (to pay taxes)
  12. 4 Open-market buy 10% owner bought 3,762 shares at an average $6.11 ($22,985)
  13. 4 Open-market buy 10% owner bought 4,305 shares at an average $6.15 ($26,493)
  14. 4 Open-market buy 10% owner bought 2,463 shares at $6.14 ($15,121)
  15. 4 Open-market buy 10% owner bought 5,432 shares at an average $6.57 ($35,689)
  16. 4 Open-market buy 10% owner bought 1,100 shares at $6.39 ($7,032)
  17. 4 Open-market buy 10% owner bought 3,900 shares at $6.31 ($24,609)
  18. 4 Open-market buy 10% owner bought 711 shares at $6.30 ($4,478)
  19. 4 Open-market buy 10% owner bought 8,992 shares at an average $6.17 ($55,488)
  20. 4 Open-market buy 10% owner bought 4,080 shares at an average $5.98 ($24,400)

Page 6 of 10 · 194 filings